• Nordson outlined portfolio and growth priorities, highlighting a high recurring revenue mix from parts and consumables.
• FY2025 revenue USD 2.8 billion; EBITDA margin 32%; gross margin 55%.
• Segment mix: Industrial Precision Solutions 48% of revenue, Medical Fluid Solutions 30%, Advanced Technology Solutions 22%.
• Medium-term targets for 2025-2029: revenue growth 6%-8% per year; adjusted EPS growth 10%-12% per year.
• M&A framework reiterated, focusing on niche end markets, differentiated technologies, EBITDA around 20%+, margin expansion, returns above cost of capital.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nordson Corporation published the original content used to generate this news brief on August 20, 2026, and is solely responsible for the information contained therein.